Picture of Santhera Pharmaceuticals Holding AG logo

SANN — Santhera Pharmaceuticals Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Santhera: Proposes Melanie Rolli As An Independent Director

March 27 (Reuters) - Santhera Pharmaceuticals Holding AG SANN.S:

SANTHERA PHARMACEUTICALS (SIX: SANN) PROPOSES TO ELECT DR. MELANIE ROLLI AS AN INDEPENDENT DIRECTOR

CURRENT BOARD MEMBER DR. OTTO SCHWARZ WILL NOT STAND FOR RE-ELECTION

Further company coverage: SANN.S

 (Reporting by Berlin Newsroom)

 ((berlin.newsroom@thomsonreuters.com;))

Recent news on Santhera Pharmaceuticals Holding AG

See all news